PDCD1 and neoplasm: Microsatellite instability-high or MMR-deficient patients showed a high response to targeting of PD-1/PD-L1 across 12 different cancer types, and p53, a classic tumor suppressor, induces PD-L1 expression in melanoma cells by modulating Janus kinase-2 expression (21, 22).